Clinical Trial Update: A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01) [Phase 3]

View source ↗

Summary

A phase 3 trial comparing BL-B01D1 with physician's choice chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma; currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• BL-B01D1
• Physician's choice chemotherapy

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING